Announcement • Mar 31
AI Maverick Intel, Inc. (OTCPK:AIMV) signed a letter of intent to acquire HEAL Access Canada Inc from HEAL Group Holdings Inc for $6.6 million. AI Maverick Intel, Inc. (OTCPK:AIMV) signed a letter of intent to acquire HEAL Access Canada Inc from HEAL Group Holdings Inc for $6.6 million on March 30, 2026. The consideration consists of 20 million common equity of AI Maverick Intel, Inc. to be issued for common equity of HEAL Access Canada Inc. As part of consideration, an undisclosed value is paid towards common equity of HEAL Access Canada Inc. The transaction will be financed through senior debt of $5 million.
The proposed transaction is expected to close upon the satisfaction of customary conditions, including completion of due diligence, minimum working capital requirements, and receipt of all required regulatory and shareholder approvals. The parties have agreed to proceed in good faith toward the negotiation and execution of a definitive agreement on or before May 29, 2026. Announcement • Jul 17
AI Maverick Intel, Inc. Launches Enhanced Prospecting Platform to Deliver Human-Like Outreach--No SDR Team Required AI Maverick Intel, Inc. announced the full rollout of its next-generation prospecting engine--enabling revenue teams to research, engage, and qualify prospects at scale without the need for additional headcount. Key Capabilities: Comprehensive contact intelligence - Millions of structured and unstructured data points are aggregated into unified profiles, surfacing job changes, buying signals, and personal preferences in real time. Context-aware communication - Adaptive language models determine the optimal channel, timing, and tone for each message, enabling the platform to support both transactional and consultative sales processes. Replicating human-quality conversations at scale opens the door to fully automated sales funnels. AI Maverick enables companies to streamline both: Transactional sales - Quotes, renewals, and re-orders managed end-to-end by the platform. Consultative sales - Needs analysis, solution-fit discussions, and personalized recommendations delivered via AI-driven, multi-step dialogues. Announcement • Nov 27
Bionoid Pharma Unveils Ai Maverick's Game-Changing Sales Automation Bionoid Pharma unveiled AI Maverick's game-changing sales automation in the latest episode of the BizUnlearned Podcast. Discover how this revolutionary platform is set to transform the traditional sales process, one touchpoint at a time. Built to solve the most common challenges of traditional sales teams, such as high SDR turnover, inefficiency, and inconsistent messaging, AI Maverick uses advanced AI and automation to replace fragmented sales processes with a unified, intelligent system. Unmatched Sales Velocity and Scale: AI Maverick addresses inefficiencies in lead targeting and follow-ups with two-way communication, acting swiftly on buyer intent signals. Whether handling 10, 100 or 100,000 interactions, the platform scales effortlessly, ensuring 24/7 engagement without compromising efficiency or personalization. Seamless Integration: The technology streamlines data management and reduces the sales cycle, moving prospects seamlessly from initial contact to conversion. Buyer-Centric Focus: AI Maverick acts on buyer intent in real-time, ensuring leads are engaged at the perfect moment. 
